Protecting Against Cerebrovascular Injury: Contributions of 12/15-Lipoxygenase to Edema Formation After Transient Focal Ischemia
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background and Purpose— The concept of the neurovascular unit suggests that effects on brain vasculature must be considered if neuroprotection is to be achieved in stroke. We previously reported that 12/15-lipoxygenase (12/15-LOX) is upregulated in the peri-infarct area after middle cerebral artery occlusion in mice, and 12/15-LOX contributes to brain damage after ischemia–reperfusion. The current study was designed to investigate 12/15-LOX involvement in vascular injury in the ischemic brain. Methods— In cell culture, a human brain microvascular endothelial cell line was subjected to either hypoxia or H 2 O 2 -induced oxidative stress with or without lipoxygenase inhibitors. For in vivo studies, mice were subjected to 90 minutes middle cerebral artery occlusion, and the effects of either 12/15-LOX gene knockout or treatment with lipoxygenase inhibitors were compared. Expression of 12/15-LOX and claudin-5 as well as extravasation of immunoglobulin G were detected by immunohistochemistry. Edema was measured as water content of brain hemispheres according to the wet–dry weight method. Results— Brain endothelial cells were protected against hypoxia and H 2 O 2 by the lipoxygenase inhibitor baicalein. After focal ischemia, 12/15-LOX was increased in neurons and endothelial cells. The vascular tight junction protein claudin-5 underwent extensive degradation in the peri-infarct area, which was partially prevented by the lipoxygenase inhibitor baicalein. Leakage of immunoglobulin G into the brain parenchyma was significantly reduced in 12/15-LOX knockout mice as well as wild-type mice treated with baicalein. Likewise, brain edema was significantly ameliorated. Conclusion— 12/15-LOX may contribute to ischemic brain damage not just by causing neuronal cell death, but also by detrimental effects on the brain microvasculature. 12/15-LOX inhibitors may thus be effective as both neuroprotectants and vasculoprotectants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Marcheselli, V. L., Hong, S., Lukiw, W. J., Tian, X. H., Gronert, K., Musto, A., Hardy, M., Gimenez, J. M., Chiang, N., Serhan, C. N., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305841200 · Cited by 802
Rosenberg, G. A. (1999) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(99)70003-4 · Cited by 278
Exciting, Radical, Suicidal: How Brain Cells Die After Stroke
Lo, E. H., Moskowitz, M. A., & Jacobs, T. P. (2005) · Stroke · doi:10.1161/01.str.0000153069.96296.fd · Cited by 246
Self-citation
Cited by
Ferroptosis: mechanisms, biology and role in disease
Jiang, X., Stockwell, B. R., & Conrad, M. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00324-8 · Cited by 7,505
The development of the concept of ferroptosis
Hirschhorn, T., & Stockwell, B. R. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.09.043 · Cited by 1,052
Blood-brain barrier tight junction permeability and ischemic stroke
Sandoval, K. E., & Witt, K. A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.08.005 · Cited by 964
Iron Homeostasis and Ferroptosis in Human Diseases: Mechanisms and Therapeutic Prospects
Ru, Q., Li, Y., Chen, L., Wu, Y., Min, J., & Wang, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01969-z · Cited by 724
Kalogeris, T., Baines, C. P., Krenz, M., & Korthuis, R. J. (2016) · Comprehensive Physiology · doi:10.1002/cphy.c160006 · Cited by 718
Regulated necrosis: disease relevance and therapeutic opportunities
Conrad, M., Angeli, J. P. F., Vandenabeele, P., & Stockwell, B. R. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.6 · Cited by 630
Mammalian lipoxygenases and their biological relevance
Kuhn, H., Banthiya, S., & van Leyen, K. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.10.002 · Cited by 624
Self-citationThe developing oligodendrocyte: key cellular target in brain injury in the premature infant
Volpe, J. J., Kinney, H. C., Jensen, F. E., & Rosenberg, P. A. (2011) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2011.02.012 · Cited by 394
Ferroptosis and necroinflammation, a yet poorly explored link
Proneth, B., & Conrad, M. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0173-9 · Cited by 374
Emerging role of 12/15-Lipoxygenase (ALOX15) in human pathologies
Singh, N. K., & Rao, G. N. (2019) · Progress in Lipid Research · doi:10.1016/j.plipres.2018.11.001 · Cited by 345
Functional and pathological roles of the 12- and 15-lipoxygenases
Dobrian, A. D., Lieb, D. C., Cole, B. K., Taylor-Fishwick, D. A., Chakrabarti, S. K., & Nadler, J. L. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.10.005 · Cited by 324
Ferroptosis Contributes to Neuronal Death and Functional Outcome After Traumatic Brain Injury*
Kenny, E. M., Fidan, E., Yang, Q., Anthonymuthu, T. S., New, L. A., Meyer, E. A., Wang, H., Kochanek, P. M., Dixon, C. E., Kagan, V. E., et al. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003555 · Cited by 302
Significance of brain tissue oxygenation and the arachidonic acid cascade in stroke
Rink, C., & Khanna, S. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3474 · Cited by 233
The role of Ca2+ in cell death caused by oxidative glutamate toxicity and ferroptosis
Maher, P., van Leyen, K., Dey, P. N., Honrath, B., Dolga, A., & Methner, A. (2018) · Cell Calcium · doi:10.1016/j.ceca.2017.05.007 · Cited by 205
“12/15-LOX is increased in neurons and endothelial cells after stroke, where it contributes to neuronal cell death and blood - brain barrier leakage [39,42].”
BackgroundSelf-citationPathophysiology of glia in perinatal white matter injury
Back, S. A., & Rosenberg, P. A. (2014) · Glia · doi:10.1002/glia.22658 · Cited by 202
“Inhibiting 12-LOX may be beneficial in the prevention of injury following ischemia to the mature brain (Jin et al., 2008; Pallast et al., 2009, 2010; Pekcec et al., 2012; van Leyen et al., 2006, 2008; Yigitkanli et al., 2012).”
BackgroundNeuroprotection by baicalein in ischemic brain injury involves PTEN/AKT pathway
Liu, C., Wu, J., Xu, K., Cai, F., Gu, J., Ma, L., & Chen, J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06561.x · Cited by 162
“Results from our laboratory and others have demonstrated that baicalein has the ability to reduce oxidative damage and exert potent neuroprotective effect in a variety of cell types and animal models including experimental ischemia (van et al. 2006; Lapchak et al. 2007; Liu et al. 2007; Jin et al. 2008), indicating th…”
Background
Metadata
- Authors
- Jin, G., Arai, K., Murata, Y., Wang, S., Stins, M. F., Lo, E. H., & van Leyen, K.
- Venue
- Stroke
- Published
- 2008-09
- Volume
- 39
- Issue
- 9
- Pages
- 2538-2543
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2168531927
- Cited by
- 153
- References
- 3
- FWCI
- 4.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.